Humana Inc. (HUM) Position Held by Teachers Retirement System of The State of Kentucky
Teachers Retirement System of The State of Kentucky held its position in shares of Humana Inc. (NYSE:HUM) during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 16,700 shares of the insurance provider’s stock at the end of the second quarter. Teachers Retirement System of The State of Kentucky’s holdings in Humana were worth $4,018,000 at the end of the most recent reporting period.
A number of other institutional investors have also bought and sold shares of the stock. Prisma Capital Partners LP bought a new stake in Humana during the second quarter worth about $7,122,000. Renaissance Technologies LLC lifted its stake in Humana by 1.5% during the second quarter. Renaissance Technologies LLC now owns 2,731,100 shares of the insurance provider’s stock worth $657,157,000 after purchasing an additional 39,400 shares during the last quarter. Parametric Portfolio Associates LLC lifted its stake in Humana by 50.8% during the second quarter. Parametric Portfolio Associates LLC now owns 413,778 shares of the insurance provider’s stock worth $99,563,000 after purchasing an additional 139,330 shares during the last quarter. Advisor Group Inc. lifted its stake in Humana by 10.5% during the second quarter. Advisor Group Inc. now owns 4,184 shares of the insurance provider’s stock worth $884,000 after purchasing an additional 399 shares during the last quarter. Finally, Nordea Investment Management AB lifted its stake in Humana by 1.0% during the second quarter. Nordea Investment Management AB now owns 7,338 shares of the insurance provider’s stock worth $1,766,000 after purchasing an additional 74 shares during the last quarter. Institutional investors and hedge funds own 95.12% of the company’s stock.
Humana Inc. (NYSE:HUM) opened at 243.63 on Friday. Humana Inc. has a 12-month low of $163.50 and a 12-month high of $259.76. The firm’s 50 day moving average price is $250.95 and its 200-day moving average price is $232.23. The stock has a market cap of $35.21 billion, a P/E ratio of 20.04 and a beta of 0.87.
Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.08 by $0.41. The business had revenue of $13.53 billion during the quarter, compared to the consensus estimate of $13.61 billion. Humana had a net margin of 3.37% and a return on equity of 15.85%. During the same quarter last year, the firm earned $2.30 earnings per share. Equities research analysts anticipate that Humana Inc. will post $11.55 earnings per share for the current fiscal year.
The company also recently disclosed a dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 29th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s payout ratio is currently 13.06%.
In other news, VP Timothy S. Huval sold 7,803 shares of Humana stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $258.14, for a total transaction of $2,014,266.42. Following the completion of the sale, the vice president now owns 8,831 shares of the company’s stock, valued at $2,279,634.34. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider William Kevin Fleming sold 3,071 shares of Humana stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $250.98, for a total transaction of $770,759.58. Following the sale, the insider now directly owns 7,681 shares of the company’s stock, valued at approximately $1,927,777.38. The disclosure for this sale can be found here. Insiders have sold 55,595 shares of company stock valued at $14,133,706 in the last ninety days. Insiders own 0.80% of the company’s stock.
Several brokerages have issued reports on HUM. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $262.00 price target for the company in a research note on Wednesday, June 7th. BidaskClub lowered Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. UBS AG reaffirmed a “neutral” rating and set a $237.00 price target (up previously from $205.00) on shares of Humana in a research note on Wednesday, June 28th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $214.00 price target on shares of Humana in a research note on Monday, June 5th. Finally, Piper Jaffray Companies reissued a “buy” rating and issued a $246.00 target price on shares of Humana in a research note on Friday, July 14th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $246.60.
ILLEGAL ACTIVITY NOTICE: This article was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/09/30/humana-inc-hum-position-held-by-teachers-retirement-system-of-the-state-of-kentucky.html.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.